Literature DB >> 2554881

Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.

P Dubreuil1, P Fulcrand, M Rodriguez, H Fulcrand, J Laur, J Martinez.   

Abstract

ACE (angiotensin-converting enzyme; peptidyl dipeptidase A; EC 3.4.15.1), cleaves C-terminal dipeptides from active peptides containing a free C-terminus. We investigated the hydrolysis of cholecystokinin-8 [CCK-8; Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2] and of various gastrin analogues by purified rabbit lung ACE. Although these peptides are amidated at their C-terminal end, they were metabolized by ACE to several peptide fragments. These fragments were analysed by h.p.l.c., isolated and identified by comparison with synthetic fragments, and by amino acid analysis. The initial and major site of hydrolysis was the penultimate peptide bond, which generated a major product, the C-terminal amidated dipeptide Asp-Phe-NH2. As a secondary cleavage, ACE subsequently released di- or tri-peptides from the C-terminal end of the remaining N-terminal fragments. The cleavage of CCK-8 and gastrin analogues was inhibited by ACE inhibitors (Captopril and EDTA), but not by other enzyme inhibitors (phosphoramidon, thiorphan, bestatin etc.). Hydrolysis of [Leu15]gastrin-(14-17)-peptide [Boc (t-butoxycarbonyl)-Trp-Leu-Asp-Phe-NH2] in the presence of ACE was found to be dependent on the chloride-ion concentration. Km values for the hydrolysis of CCK-8, [Leu15]gastrin-(11-17)-peptide and Boc-[Leu15]gastrin-(14-17)-peptide at an NaCl concentration of 300 mM were respectively 115, 420 and 3280 microM, and the catalytic constants were about 33, 115 and 885 min-1. The kcat/Km for the reactions at 37 degrees C was approx. 0.28 microM-1.min-1, which is approx. 35 times less than that reported for the cleavage of angiotensin I. These results suggest that ACE might be involved in the metabolism in vivo of CCK and gastrin short fragments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554881      PMCID: PMC1133238          DOI: 10.1042/bj2620125

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Investigation on the metabolism of CCK8 analogues by rat brain slices.

Authors:  C Durieux; B Charpentier; D Pelaprat; B P Roques
Journal:  Neuropeptides       Date:  1986-01       Impact factor: 3.286

2.  Activation of angiotensin converting enzyme by monovalent anions.

Authors:  P Bünning; J F Riordan
Journal:  Biochemistry       Date:  1983-01-04       Impact factor: 3.162

3.  Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone.

Authors:  R A Skidgel; E G Erdös
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Phenethyl ester derivative analogues of the C-terminal tetrapeptide of gastrin as potent gastrin antagonists.

Authors:  J Martinez; M Rodriguez; J P Bali; J Laur
Journal:  J Med Chem       Date:  1986-11       Impact factor: 7.446

5.  Catabolism of substance P in the stomach wall of the rat.

Authors:  N W Bunnett; M S Orloff; A J Turner
Journal:  Life Sci       Date:  1985-08-19       Impact factor: 5.037

6.  Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.

Authors:  M A Cascieri; H G Bull; R A Mumford; A A Patchett; N A Thornberry; T Liang
Journal:  Mol Pharmacol       Date:  1984-03       Impact factor: 4.436

7.  Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone.

Authors:  J Martinez; J P Bali; M Rodriguez; B Castro; R Magous; J Laur; M F Lignon
Journal:  J Med Chem       Date:  1985-12       Impact factor: 7.446

Review 8.  The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme.

Authors:  A A Patchett; E H Cordes
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1985

9.  Novel substrates for angiotensin I converting enzyme.

Authors:  L B Hersh; J T Gafford; J C Powers; T Tanaka; E G Erdös
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575

10.  Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase.

Authors:  R A Skidgel; S Engelbrecht; A R Johnson; E G Erdös
Journal:  Peptides       Date:  1984 Jul-Aug       Impact factor: 3.750

View more
  14 in total

1.  The endopeptidase activity and the activation by Cl- of angiotensin-converting enzyme is evolutionarily conserved: purification and properties of an an angiotensin-converting enzyme from the housefly, Musca domestica.

Authors:  N S Lamango; M Sajid; R E Isaac
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

2.  Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice.

Authors:  Nathalie Esser; Christine Schmidt; Breanne M Barrow; Laura Cronic; Daryl J Hackney; Stephen M Mongovin; Meghan F Hogan; Andrew T Templin; Joseph J Castillo; Rebecca L Hull; Sakeneh Zraika
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

Review 3.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

4.  Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  K J Rieger; N Saez-Servent; M P Papet; J Wdzieczak-Bakala; J L Morgat; J Thierry; W Voelter; M Lenfant
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

Review 5.  Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions.

Authors:  Maximilian Klingler; Anton Amadeus Hörmann; Elisabeth Von Guggenberg
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

6.  Expression of neutral endopeptidase activity during clinical and experimental acute lung injury.

Authors:  Soshi Hashimoto; Fumimasa Amaya; Kentaro Oh-Hashi; Kazutoshi Kiuchi; Satoru Hashimoto
Journal:  Respir Res       Date:  2010-11-29

7.  The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study.

Authors:  Elisabeth Altmaier; Cristina Menni; Margit Heier; Christa Meisinger; Barbara Thorand; Jan Quell; Michael Kobl; Werner Römisch-Margl; Ana M Valdes; Massimo Mangino; Melanie Waldenberger; Konstantin Strauch; Thomas Illig; Jerzy Adamski; Tim Spector; Christian Gieger; Karsten Suhre; Gabi Kastenmüller
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

8.  Blockade of the renin-angiotensin system suppresses hydroxyl radical production in the rat striatum during carbon monoxide poisoning.

Authors:  Shuichi Hara; Masamune Kobayashi; Fumi Kuriiwa; Hajime Mizukami; Toshiji Mukai
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

9.  Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism.

Authors:  Elisabeth Altmaier; Gisela Fobo; Margit Heier; Barbara Thorand; Christine Meisinger; Werner Römisch-Margl; Melanie Waldenberger; Christian Gieger; Thomas Illig; Jerzy Adamski; Karsten Suhre; Gabi Kastenmüller
Journal:  Eur J Epidemiol       Date:  2014-05-10       Impact factor: 8.082

10.  Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation.

Authors:  Aikaterini Kaloudi; Berthold A Nock; Emmanouil Lymperis; Roelf Valkema; Eric P Krenning; Marion de Jong; Theodosia Maina
Journal:  EJNMMI Res       Date:  2016-02-16       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.